Untargeted Metabolomic Analysis of the Effects and Mechanism of Nuciferine Treatment on Rats With Nonalcoholic Fatty Liver Disease

Araujo, 1998, Liver and biliary ultrasonography in diabetic and non-diabetic obese women, Diabetes Metab., 24, 458, 10.1177/014572179802400611

Bell, 2010, Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome p-450 protein content, Ann. Surg., 251, 1041, 10.1097/sla.0b013e3181dbb572

Bell, 2011, Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes, J. Clin. Gastroenterol., 45, 800, 10.1097/MCG.0b013e31821377e4

Boza, 2005, Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass, Obes. Surg., 15, 1148, 10.1381/0960892055002347

Braud, 2017, Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat model, J. Nutr. Biochem., 40, 95, 10.1016/j.jnutbio.2016.10.012

Caligiuri, 2014, Evidence for the use of glomerulomegaly as a surrogate marker of glomerular damage and for alpha-linolenic acid-rich oils in the treatment of early obesity-related glomerulopathy in a diet-induced rodent model of obesity, Appl. Physiol. Nutr. Metab., 39, 951, 10.1139/apnm-2013-0476

Calzada, 2016, Phosphatidylethanolamine Metabolism in Health and Disease, Int. Rev. Cell Mol. Biol., 321, 29, 10.1016/bs.ircmb.2015.10.001

Castro-Martinez, 2012, Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome, Cir. Cir., 80, 128

Chen, 2008, Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease, J. Zhejiang Univ. Sci. B., 9, 616, 10.1631/jzus.B0720016

Choi, 2012, Differential gene expression in pancreatic tissues of streptozocin-induced diabetic rats and genetically-diabetic mice in response to hypoglycemic dipeptide cyclo (his-pro) treatment, Mol. Biol. Rep., 39, 8821, 10.1007/s11033-012-1746-1

Cui, 2017, Icariin-treated human umbilical cord mesenchymal stem cells decrease chronic liver injury in mice, Cytotechnology, 69, 19, 10.1007/s10616-016-0034-7

Cui, 2018, Berberine Regulates Treg/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon, Front. Pharmacol., 9, 10.3389/fphar.2018.00571

Ding, 2015, Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet, Eur. J. Pharmacol., 761, 405, 10.1016/j.ejphar.2015.05.005

El-Din, 2014, Pharmacological and antioxidant actions of garlic and.or onion in non-alcoholic fatty liver disease (NAFLD) in rats, J. Egypt Soc Parasitol., 44, 295, 10.12816/0006468

Fisher, 2009, Hepatic cytochrome p450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease, Drug Metab. Dispos., 37, 2087, 10.1124/dmd.109.027466

Guo, 2013, Nuciferine Prevents Hepatic Steatosis and Injury Induced by a High-Fat Diet in Hamsters, PLoS One, 8, 10.1371/journal.pone.0063770

Han, 2008, Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes, J. Lipid Res., 49, 84, 10.1194/jlr.m700184-jlr200

Jiang, 2016, Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat, World J. Gastroenterol., 22, 10180, 10.3748/wjg.v22.i46.10180

Kind, 2009, FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry, Anal. Chem., 81, 10038, 10.1021/ac9019522

King, 2019, Development of a rapid profiling method for the analysis of polar analytes in urine using HILIC-MS and ion mobility enabled HILIC-MS, Metabolomics, 15, 17, 10.1007/s11306-019-1474-9

Kobyliak, 2014, The role of liver biopsy to assess non-alcoholic fatty liver disease, Rev. Recent Clin. Trials, 9, 159, 10.2174/1574887109666141216102231

Koo, 2013, Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis, Clin. Mol. Hepatol., 19, 210, 10.3350/cmh.2013.19.3.210

Li, 2006, The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis, Cell Metab., 3, 321, 10.1016/j.cmet.2006.03.007

Li, 2020, Hua-Zhuo-Kai-Yu decoction inhibits apoptosis in nonalcoholic fatty liver disease, Tradit. Med. Res., 1, 10.12032/TMR20200201157

Livak, 2002, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 25, 402, 10.1006/meth.2001.1262

Masarone, 2014, Non alcoholic fatty liver: epidemiology and natural history, Rev. Recent Clin. Trials, 9, 126, 10.2174/1574887109666141216111143

Mesens, 2012, Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP, Toxicol. Pathol., 40, 491, 10.1177/0192623311432290

Ning, 2019, Nuciferine prevents hepatic steatosis by regulating lipid metabolismin diabetic rat model, Open Life Sci., 14, 699, 10.1515/biol-2019-0079

Sun, 2020, Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model, Biomed. Pharmacother., 123, 10.1016/j.biopha.2019.109721

Thomsen, 2018, Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis, Med. Hypotheses, 113, 91, 10.1016/j.mehy.2018.02.010

Vaittinen, 2015, Fads2 genotype regulates delta-6 desaturase activity and inflammation in human adipose tissue, J. L Res., 57, 56, 10.1194/jlr.M059113

Van Der Veen, 2017, The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease, Biochim. Biophys. Acta Biomembr., 1859, 1558, 10.1016/j.bbamem.2017.04.006

Vander Heiden, 1997, BclxL Regulates the Membrane Potential and Volume Homeostasis of Mitochondria, Cell, 91, 627, 10.1016/S0092-8674(00)80450-X

Wang, 2016, Nuciferine alleviates renal injury by inhibiting inflammatory responses in fructose-fed rats, J. AGR Food Chem., 64, 7899, 10.1021/acs.jafc.6b03031

Wang, 2017, Rosiglitazone Improves Insulin Resistance Mediated by 10,12 Conjugated Linoleic Acid in a Male Mouse Model of Metabolic Syndrome, Endocrinology, 158, 2848, 10.1210/en.2017-00213

Wilkins, 2013, Nonalcoholic fatty liver disease: diagnosis and management, Am. Fam. Physician, 88, 35, 10.1556/OH.2013.29674

Xie, 2019, Jian-Gan-Xiao-Zhi decoction ameliorates high-fat high-carbohydrate diet-induced non-alcoholic fatty liver disease and insulin resistance by regulating the AMPK/JNK pathway, Tradit. Med. Res., 1

Xu, 2019, Metabolomics Characterizes the Effects and Mechanisms of Quercetin in Nonalcoholic Fatty Liver Disease Development, Int. J. Mol. Sci., 20, E1220, 10.3390/ijms20051220

Ye, 2018, Pharmacokinetics of nuciferine and n-nornuciferine, two major alkaloids from nelumbo nucifera leaves, in rat plasma and the brain, Front. Pharmacol., 9, 10.3389/fphar.2018.00902

Younossi, 2019, The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis, J. Hepatol., 71, 793, 10.1016/j.jhep.2019.06.021

Yu, 2017, Metabonomics Research Progress on Liver Diseases, Can. J. Gastroenterol. Hepatol., 2017, 10.1155/2017/8467192

Zeng, 2016, Impaired reverse cholesterol transport and hepatic steatosis contribute to pathogenesis of high fat diet-induced hyperlipidemia in murine models, Trop. J. Pharm. Res., 15, 701, 10.4314/tjpr.v15i4.5

Zhang, 2015, Nuciferine downregulates Per-Arnt-Sim kinase expression during its alleviation of lipogenesis and inflammatory on oleic acid-induced hepatic steatosis in HepG2 cells, Front. Pharmacol., 6, 10.3389/fphar.2015.00238